The Journal of Pediatrics
Volume 143, Issue 1 , Pages 4-6 , July 2003

Congenital cytomegalovirus (CMV) infections: hats off to Alabama

  • Charles G. Prober, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Charles G. Prober, MD, Professor of Pediatrics, Microbiology and Immunology, Scientific Director, Glaser Pediatric Research Network, Stanford University School of Medicine, Stanford, CA 94305-5208.
    • ,
  • Andrea M. Enright, MD

References 

  1. Prober CG. Introduction to Herpesviridae. In:  Long SS,  Pickering LP,  Prober CG editor. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingstone; 2003;p. 1031–1032
  2. Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics. 1980;66:758–762
  3. Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?. J Pediatr. 1999;135:60–64
  4. Pass RF. Viral infections in the fetus and newborn. In:  Long SS,  Pickering LP,  Prober CG editor. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingstone; 2003;p. 543–546
  5. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RI, Walton PD, et al.  Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA. 1986;256:1904–1908
  6. Pass RF. Cytomegalovirus. In:  Long SS,  Pickering LP,  Prober CG editor. Principles and practice of pediatric infectious diseases. 2nd ed. Philadelphia: Churchill Livingstone; 2003;p. 1050–1058
  7. Reynolds DW, Stagno S, Hosty TS, Tiller M, Alford CA. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med. 1973;289:1–5
  8. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104:55–60
  9. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptual immunity. N Engl J Med. 2001;344:1366–1371
  10. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA. 2003;289:1008–1011
  11. Demmler GJ. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis. 1991;13:315–329
  12. Yow MD, Demmler GJ. Congenital cytomegalovirus disease-20 years is long enough. N Engl J Med. 1992;326:702–703
  13. The Jordan Report 2000: Accelerated Development of Diseases. National Institutes of Health: National Institute of Allergy and Infectious Diseases; 2000. National Institute of Allergy and Infectious Diseases; 2000;
  14. Adler SP, Stuart ES, Plotkin SA, Hempfling SH, Buis J, Manning ML, et al.  Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis. 1995;171:26–32
  15. Britt WJ, Vugler L, Stephens EB. Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J Virol. 1998;62:3309–3318
  16. Pass RF, Duliege AM, Boppana S, Sekulovich R, Percell S, Britt W, et al.  Subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and new adjuvant. J Infect Dis. 1999;180:970–975
  17. Rivera LB, Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatrics. 2002;110:762–767
  18. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130:624–630
  19. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis. 1990;12(Suppl 7):S745–S753
  20. Trang JM, Kidd L, Gruber W, Storch G, Demmler G, Jacobs R, et al.  The NIAID Collaborative Antiviral Study Group  Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clin Pharmacol Ther. 1993;53:15–21
  21. Zhou XJ, Gruber W, Demmler G, Jacobs R, Reuman P, Adler S, et al.  The NIAID Collaborative Antiviral Study Group  Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Antimicrob Agents Chemother. 1996;40:2202–2205
  22. Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, et al.  The NIAID Collaborative Antiviral Study Group  Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. J Infect Dis. 1997;175:1080–1086
  23. Kimberlin DW, Lin C-Y, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al.  The NIAID Collaborative Antiviral Study Group  Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:17–26
  24. In:  Pinckering LP editors. Red Book 2003. Report on the Committee on Infectious Diseases. 26th Edition. American Academy of Pediatrics; 2003;
  25. Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, et al.  The Valganciclovir Study Group  A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med. 2002;346:1119–1126

PII: S0022-3476(03)00290-7

doi: 10.1016/S0022-3476(03)00290-7

The Journal of Pediatrics
Volume 143, Issue 1 , Pages 4-6 , July 2003

Article Tools